Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-Chang Hu

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 23, 2009
Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method--analysis of 2010 Taiwanese patientsChien-Hung Chen, Fu-Chang Hu, Guan-Tarn Huang, et al.
Surgery|January 19, 2023
Quality of life outcomes after surgical intervention in patients with multiple rib fractures: A prospective cohort studyKuan-Hsun Lian, Chi-Cheng Yang, Fu-Chang Hu, et al.
Annals of Surgical Oncology|August 8, 2007
Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinomaYuh-Yu Chou, Yung-Ming Jeng, Tan-Tsao Lee, et al.
BMC Cancer|August 31, 2010
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCCZhong-Zhe Lin, Yung-Ming Jeng, Fu-Chang Hu, et al.
Antioxidants & Redox Signaling|June 22, 2013
Do interleukin-10 and superoxide ions predict outcomes of cardiac extracorporeal membrane oxygenation patients?Tsai-Hsia Hong, Shuenn-Wen Kuo, Fu-Chang Hu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2019
Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinomaZhong-Zhe Lin, Chiun Hsu, Yung-Ming Jeng, et al.
Cancer Medicine|September 22, 2023
Disparity in survival benefits of pembrolizumab between Asian and non-Asian patients with advanced cancers: A systematic review and meta-regression analysisShang-Hsuan Peng, Ching-Hung Lin, I-Chun Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2008
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trialChiun Hsu, Sung-Hsin Kuo, Fu-Chang Hu, et al.
Breast Cancer Research and Treatment|July 5, 2024
Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian womenHsing-Wu Chen, Wen-Hung Kuo, Yen-Shen Lu, et al.
The Journal of Infection|May 17, 2011
Risk factors of hepatitis during anti-tuberculous treatment and implications of hepatitis virus loadJann-Yuan Wang, Chen-Hua Liu, Fu-Chang Hu, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|January 23, 2009
Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method--analysis of 2010 Taiwanese patientsChien-Hung Chen, Fu-Chang Hu, Guan-Tarn Huang, et al.
Surgery|January 19, 2023
Quality of life outcomes after surgical intervention in patients with multiple rib fractures: A prospective cohort studyKuan-Hsun Lian, Chi-Cheng Yang, Fu-Chang Hu, et al.
Annals of Surgical Oncology|August 8, 2007
Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinomaYuh-Yu Chou, Yung-Ming Jeng, Tan-Tsao Lee, et al.
BMC Cancer|August 31, 2010
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCCZhong-Zhe Lin, Yung-Ming Jeng, Fu-Chang Hu, et al.
Antioxidants & Redox Signaling|June 22, 2013
Do interleukin-10 and superoxide ions predict outcomes of cardiac extracorporeal membrane oxygenation patients?Tsai-Hsia Hong, Shuenn-Wen Kuo, Fu-Chang Hu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 31, 2019
Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinomaZhong-Zhe Lin, Chiun Hsu, Yung-Ming Jeng, et al.
Cancer Medicine|September 22, 2023
Disparity in survival benefits of pembrolizumab between Asian and non-Asian patients with advanced cancers: A systematic review and meta-regression analysisShang-Hsuan Peng, Ching-Hung Lin, I-Chun Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2008
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trialChiun Hsu, Sung-Hsin Kuo, Fu-Chang Hu, et al.
Breast Cancer Research and Treatment|July 5, 2024
Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian womenHsing-Wu Chen, Wen-Hung Kuo, Yen-Shen Lu, et al.
The Journal of Infection|May 17, 2011
Risk factors of hepatitis during anti-tuberculous treatment and implications of hepatitis virus loadJann-Yuan Wang, Chen-Hua Liu, Fu-Chang Hu, et al.
Pageof 13